Reference - Detail
|Author||Abdelrhman Y, Gepreel MA, Kobayashi S, Okano S, Okamoto T.|
|Title||Biocompatibility of new low-cost (α + β)-type Ti-Mo-Fe alloys for long-term implantation.|
|Journal||Mater Sci Eng C Mater Biol Appl|
, respectively. These values are more compatible with biomedical applications than those measured for the Ti-6Al-4V ELI alloy. Furthermore, the cell viabilities of the TMF6 and TMF8 alloys indicate their improved compatibility compared to that of the Ti-6Al-4V ELI alloy. The CCK-8 (Cell Counting Kit-8) assay was conducted to investigate the cytotoxicity, proliferation, and shape index of the cells of the candidate alloys. Overall, the measured compatibility of the new V-free low-cost alloys, particularly TMF8, makes them promising candidates for replacing the Ti-6Al-4V ELI alloy in biomedical applications.
|MeSH||Alloys / economics Alloys / pharmacology* Animals Biocompatible Materials / economics* Biocompatible Materials / pharmacology* Cell Death / drug effects Cell Line Cell Shape / drug effects Cell Size / drug effects Cell Survival / drug effects Corrosion Costs and Cost Analysis* Cytoskeleton / drug effects Cytoskeleton / metabolism Dielectric Spectroscopy Elastic Modulus Electrochemical Techniques Hardness Iron / pharmacology* Mice Molybdenum / pharmacology* Prosthesis Implantation* Stress, Mechanical Tensile Strength Titanium / pharmacology* X-Ray Diffraction|
|Human and Animal Cells||MC3T3-E1(RCB1126)|